New cancer drug injected directly into tumors enters human testing

NCT ID NCT06249048

Summary

This is the first study in people testing an experimental drug called STX-001, which is injected directly into tumors. Researchers want to see if it is safe and if it can help shrink tumors in adults with advanced cancers that have stopped responding to standard treatments. The study will test STX-001 by itself and also combined with an existing immunotherapy drug (pembrolizumab), focusing on cancers like melanoma and triple-negative breast cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cleveland Clinic

    NOT_YET_RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • HonorHealth Research and Innovation Institute

    NOT_YET_RECRUITING

    Scottsdale, Arizona, 85258, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Huntsman Cancer Institute - University of Utah

    NOT_YET_RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Melanoma Institute Australia

    RECRUITING

    Wollstonecraft, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NextGen Oncology

    RECRUITING

    Beverly Hills, California, 90212, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.